Na+/Ca2+ exchange inhibitor, KB-R7943, attenuates contrast-induced acute kidney injury

Journal of Nephrology

Volumn 26, Issue 5, 2013, Pages 877-885

  Yang, Dingwei ^a   Yang, Dingping ^b   Jia, Ruhan ^b   Tan, Jin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Acute kidney injury; Contrast media; Hemodynamics; Na+ Ca2+ exchanger; Oxidative stress

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; CATALASE; CREATININE; ENDOTHELIN 1; MALONALDEHYDE; MEGLUMINE DIATRIZOATE; SODIUM CALCIUM EXCHANGE PROTEIN; TRIACYLGLYCEROL; 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; CONTRAST MEDIUM; DIATRIZOATE; THIOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG DOSE COMPARISON; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY TUBULE NECROSIS; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL ARTERY; RENAL PROTECTION; RESISTIVE INDEX; ACUTE KIDNEY INJURY; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; KIDNEY TUBULE; METABOLISM; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION; WISTAR RAT;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CATALASE; CONTRAST MEDIA; CREATININE; DIATRIZOATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; KIDNEY; KIDNEY TUBULES; MALE; MALONDIALDEHYDE; NECROSIS; RATS; RATS, WISTAR; SODIUM-CALCIUM EXCHANGER; THIOUREA; VASCULAR RESISTANCE;

EID: 84884626796     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000259     Document Type: Article

References (33)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39(5): 930-936.
2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983; 74(2): 243-248.
3. Duan SB, Liu FY, Luo JA, et al. Nephrotoxicity of highand low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol. 2000; 41(5): 503-507.
4. Yamashita J, Itoh M, Kuro T, et al. Pre-or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KBR7943, shows renal protective effects in rats with ischemic acute renal failure. J Pharmacol Exp Ther. 2001; 296(2): 412-419.
5. Ladilov Y, Haffner S, Balser-Schäfer C, Maxeiner H, Piper HM. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol. 1999; 276(6 Pt 2): H1868-H1876.
6. Watano T, Kimura J, Morita T, Nakanishi H. A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guineapig cardiac ventricular cells. Br J Pharmacol. 1996; 119(3): 555-563.
7. Yamashita J, Ogata M, Takaoka M, Matsumura Y. KBR7943, a selective Na+/Ca2+ exchange inhibitor, protects against ischemic acute renal failure in mice by inhibiting renal endothelin-1 overproduction. J Cardiovasc Pharmacol. 2001; 37(3): 271-279.
8. Yamashita J, Kita S, Iwamoto T, et al. Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger. J Pharmacol Exp Ther. 2003; 304(1): 284-293.
9. Dingping Y, Ruhan J, Guohua D, Dingwei Y, Xiaoling X. [Reverse mode of Na+/Ca2+ exchanger inhibitor, KB-R7943 attenuates tubular epithelial cell apoptosis induced by contrast media] [article in Chinese]. Chin J Emerg Med. 2008; 7: 713-716.
10. Feldstein A, Krier JD, Sarafov MH, et al. In vivo renal vascular and tubular function in experimental hypercholesterolemia. Hypertension. 1999; 34(4 Pt 2): 859-864.
11. Stulak JM, Lerman A, Caccitolo JA, et al. Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia. Atherosclerosis. 2001; 154(1): 195-201.
12. Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney Int. 1998; 53(6): 1736-1742.
13. Yang DW, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J (Engl). 2004; 117(4): 542-546.
14. Yang D, Lin S, Yang D, Wei L, Shang W. Effects of short-and long-term hypercholesterolemia on contrast-induced acute kidney injury. Am J Nephrol. 2012; 35(1): 80-89.
15. Finn WF. The clinical and renal consequences of contrastinduced nephropathy. Nephrol Dial Transplant. 2006; 21(6) (Supplement 1): i2-i10.
16. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86(1): 271-278.
17. Wilson DR, Arnold PE, Burke TJ, Schrier RW. Mitochondrial calcium accumulation and respiration in ischemic acute renal failure in the rat. Kidney Int. 1984; 25(3): 519-526.
18. Neumayer HH, Junge W, Küfner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant. 1989; 4(12): 1030-1036.
19. Goldfarb D, Iaina A, Serban I, Gavendo S, Kapuler S, Eliahou HE. Beneficial effect of verapamil in ischemic acute renal failure in the rat. Proc Soc Exp Biol Med. 1983; 172(3): 389-392.
20. Philipson KD, Nicoll DA, Ottolia M, et al. The Na+/Ca2+ exchange molecule: an overview. Ann N Y Acad Sci. 2002; 976(1): 1-10.
21. Condrescu M, Opuni K, Hantash BM, Reeves JP. Cellular regulation of sodium-calcium exchange. Ann N Y Acad Sci. 2002; 976(1): 214-223.
22. Nicoll DA, Longoni S, Philipson KD. Molecular cloning and functional expression of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. Science. 1990; 250(4980): 562-565.
23. Li Z, Matsuoka S, Hryshko LV, et al. Cloning of the NCX2 isoform of the plasma membrane Na(+)-Ca2+ exchanger. J Biol Chem. 1994; 269(26): 17434-17439.
24. Nicoll DA, Quednau BD, Qui Z, Xia YR, Lusis AJ, Philipson KD. Cloning of a third mammalian Na+-Ca2+ exchanger, NCX3. J Biol Chem. 1996; 271(40): 24914-24921.
25. Morcos SK, Epstein FH, Haylor J, Dobrota M. Aspects of contrast media nephrotoxicity. Eur J Radiol. 1996; 23(3): 178-184.
26. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332(6163): 411-415.
27. Margulies KB, Hildebrand FLJ, Heublein DM, Burnett JC Jr. Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol. 1991; 2(5): 1041-1045.
28. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol. 1992; 3(1): 58-65.
29. Brooks DP, DePalma PD. Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670. Nephron. 1996; 72(4): 629-636.
30. Xiong XL, Jia RH, Yang DP, Ding GH. Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. Pharmacol Res. 2006; 54(4): 253-260.
31. Yu L, Netticadan T, Xu YJ, Panagia V, Dhalla NS. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther. 1998; 286(1): 1-8.
32. Cross HR, Radda GK, Clarke K. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study. Magn Reson Med. 1995; 34(5): 673-685.
33. Scholz W, Albus U, Lang HJ, et al. Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol. 1993; 109(2): 562-568.